Robin Williams On Antidepressant at Time of Suicide
Robin Williams had "therapeutic" levels of the tetra-cyclic antidepressant mirtazapine in his blood at the time of his suicide, according to the coroner's report...
Contribution of Antipsychotics to Suicidality and Depression
Peter Lehmann reviews the contribution of antipsychotics to suicide and depression in schizophrenia in the current International Journal of Psychotherapy. Publications about the intrinsic effects of...
The Case Against Antipsychotics
This review of the scientific literature, stretching across six decades, makes the case that antipsychotics, over the long-term, do more harm than good. The drugs lower recovery rates and worsen functional outcomes over longer periods of time.
The Evidence-Based Mind of Psychiatry on Display
The writings of Pies and his colleagues, I believe, provide a compelling case study of cognitive dissonance. Cognitive dissonance arises when people are presented with information that creates conflicted psychological states, challenging some belief they hold dear, and people typically resolve dissonant states by sifting through information in ways that protect their self-esteem and their financial interests. It is easy to see that process operating here.
Vitamin B6 Effective in Reducing Antipsychotic Induced Akathisia
A recent RCT showed that vitamin B6 is as effective as propranolol for the treatment of akathisia.
Psychiatry Defends Its Antipsychotics: A Case Study of Institutional Corruption
Jeffrey LIeberman and colleagues have published a paper in the American Journal of Psychiatry stating that there is no evidence that psychiatric drugs cause long-term harm, and that the evidence shows that these drugs provide a great benefit to patients. A close examination of their review reveals that it is a classic example of institutional corruption, which was meant to protect guild interests.
8 Years of Mental Health Research Distilled to 4 Infographics
Pictures are worth a thousand words. So Iâve chosen pictures to distill the mountain of mental health research Iâve examined over the last eight years. Three infographics summarize research on psychiatric drugs, and one asserts why I think Integrative Mental Health is the best path available for mental health recovery.
Researcher Acknowledges His Mistakes in Understanding Schizophrenia
Sir Robin Murray, a professor at the Institute of Psychiatry, Psychology, and Neuroscience in London, states that he ignored social factors that contribute to âschizophreniaâ for too long. He also reports that he neglected the negative effects antipsychotic medication has on the brain.
Study Deems Support, Not Drugs, Best for Youth at Risk of Psychosis
Research by five U.K. universities across multiple sites for up to two years divided 288 young adults (14-35 years) deemed at risk for psychosis...
Harrow + Wunderink + Open Dialogue = An Evidence-based Mandate for A New Standard...
In the wake of the new study by Dutch researcher Lex Wunderink, it is time for psychiatry to do the right thing and acknowledge that, if it wants to do best by its patients, it must change its protocols for using antipsychotics. The current standard of care, whichâin practiceâinvolves continual use of antipsychotics for all patients diagnosed with a psychotic disorder, clearly reduces the opportunity for long-term functional recovery.
No More Tears? The Shame of Johnson & Johnson
In 1972, prisoners at Holmesburg Prison in Philadelphia were paid $3 to have their eyes held open with clamps and hooks while Johnson & Johnson's baby shampoo was dropped into them. In 2011, mothers of newborns were arrested when their babies tested positive for exposure to cannabis, a false result caused by the use of Johnson & Johnsonâs Head-to-Toe Foaming Baby Wash. Young men have undergone mastectomies to remove breasts grown as a result of Johnson & Johnson antipsychotics, which were used as a result of Johnson & Johnson's criminal promotion of its drugs for off-label purposes. And now, Johnson & Johnson has announced the removal of carcinogenic chemicals from their No More Tears baby shampoo.
FDA Warns About New Impulse-Control Problems Associated With Abilify
Yesterday, the US Food and Drug Administration (FDA) released a warning that the antipsychotic drug aripiprazole or Abilify is associated with compulsive and uncontrollable...
Researchers Warn of âBrain Atrophyâ in Children Prescribed Antipsychotics
Researchers discuss the evidence that antipsychotic medications may cause brain atrophy in children, whose brains are still developing.
Gradual Tapering is Most Successful for Withdrawal from Antipsychotics
Mixed-Methods study explores the experiences of antipsychotic discontinuation among service users.
Scientists Clarify Risks of Augmenting with Antipsychotic Medications for Depression
The researchers found that while antipsychotic drugs may be slightly more effective than alternative antidepressants, they come with a much higher side effect burden.
J&J to Pay $2.2B to Settle Off-Label Risperdal Marketing Case
Johnson & Johnson and its subsidiaries will pay more than $2.2 billion - one of the largest health-care fraud settlements in history - to...
Long-Term Antipsychotics: Making Sense of the Evidence in the Light of the Dutch Follow-Up...
In the 1950s, when the drugs we now call âantipsychoticsâ first came along, psychiatrists recognised that they were toxic substances that happened to have the ability to suppress thoughts and emotions without simply putting people to sleep in the way the old sedatives did. The mental restriction the drugs produced was noted to be part of a general state of physical and mental inhibition that at extremes resembled Parkinsonâs disease. Early psychiatrists didnât doubt that this state of neurological suppression was potentially damaging to the brain.
Timberrr! Psychiatryâs Evidence Base For Antipsychotics Comes Crashing to the Ground
When I wrote Anatomy of an Epidemic, one of my foremost hopes was that it would prompt mainstream researchers to revisit the scientific literature. Was there evidence that any class of psychiatric medicationsâantipsychotics, antidepressants, stimulants, benzodiazepines, and so forthâprovided a long-term benefit? Now epidemiologists at Columbia University and City College of New York have reported that they have done such an investigation about antipsychotics, and their bottom-line finding can be summed up in this way: Psychiatryâs âevidence baseâ for long-term use of these drugs does not exist.
Abolishing Forced Treatment in Psychiatry is an Ethical Imperative
Forced treatment in psychiatry cannot be defended, neither on ethical, legal or scientific grounds. It has never been shown that forced treatment does more good than harm, and it is highly likely that the opposite is true. We need to abolish our laws about this, in accordance with the United NaÂtions Convention on the Rights of Persons with Disabilities, which virtually all countries have ratified.
Researchers Test Harms and Benefits of Long Term Antipsychotic Use
Researchers from the City College of New York and Columbia University published a study this month testing the hypothesis that people diagnosed with schizophrenia treated long-term with antipsychotic drugs have worse outcomes than patients with no exposure to these drugs. They concluded that there is not a sufficient evidence base for the standard practice of long-term use of antipsychotic medications.
The Road to Perdition
The recent research scandals out of the University of Minnesotaâs Department of Psychiatry may be alarming, but they are not new. Back in the 1990s, when the university was working its way towards a crippling probation by the National Institutes of Health (for yet another episode of misconduct (this time in the Department of Surgery), the Department of Psychiatry hosted two spectacular cases of research wrongdoing, both of which resulted in faculty members being disqualified from conducting research by the FDA.
Antipsychotics and Brain Shrinkage: An Update
Evidence that antipsychotics cause brain shrinkage has been accumulating over the last few years, but the psychiatric research establishment is finding its own results difficult to swallow. A new paper by a group of American researchers once again tries to âblame the disease,â a time-honoured tactic for diverting attention from the nasty and dangerous effects of some psychiatric treatments. People need to know about this research because it indicates that antipsychotics are not the innocuous substances that they have frequently been portrayed as. We still have no conclusive evidence that the disorders labeled as schizophrenia or psychosis are associated with any underlying abnormalities of the brain, but we do have strong evidence that the drugs we use to treat these conditions cause brain changes.
A Commentary on the Finnish Analysis of Outcomes of First Episode Schizophrenia
There are a number of well-recognised problems with this sort of study and we should be very cautious about accepting its conclusions at face value. The main problem is that it is an âobservationalâ study, not a randomised controlled trial, and these analyses can be seriously misleading.Â
Does Long-Term Use of âAntipsychoticâ Drugs Result in More Disability, and More Psychosis?
This sounds like a weird question â everyone knows that psychosis is often very disabling, and antipsychotic drugs are widely recognized for their effects in reducing psychosis in at least most people, and most often taking effect in just a few days. And when people become psychotic again, itâs often understood that itâs because they âwerenât taking their meds.â But what if itâs trickier than that? What if âantipsychoticâ drugs make things better in the short term, but make long term problems worse? How would we even know?
Mental Health Professionals and Patients Often Disagree on Causes of Symptoms
A new study finds that cliniciansâ disregard for mental health patientsâ insight into their own condition may be detrimental to treatment.